Entwicklung einer akuten myeloischen Leukämie unter adjuvanter Therapie mit Olaparib nach neoadjuvanter Chemotherapie eines triple-negativen Mammakarzinoms – eine Kasuistik

Translated title of the contribution: Development of acute myeloid leukemia during adjuvant treatment with olaparib following neoadjuvant chemotherapy of triple-negative breast cancer—a case report

Kristina Wihlfahrt*, Peer Jansen, Lars Fransecky, Karin Huber, Henriette Princk, Marion van Mackelenbergh, Nicolai Maass, Maggie Banys-Paluchowski

*Corresponding author for this work
Translated title of the contributionDevelopment of acute myeloid leukemia during adjuvant treatment with olaparib following neoadjuvant chemotherapy of triple-negative breast cancer—a case report
Original languageGerman
JournalGynakologie
Volume57
Issue number6
Pages (from-to)425-428
Number of pages4
ISSN2731-7102
DOIs
Publication statusPublished - 06.2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)

DFG Research Classification Scheme

  • 2.22-14 Hematology, Oncology
  • 2.22-21 Gynaecology and Obstetrics

Cite this